FDA ponders loosening ELA process

FDA ponders loosening ELA process

WASHINGTON - The FDA announced that it is considering eliminating establishment licenses (ELAs) for well-characterized biotechnology products. It also announced the availiabiity of a Guidance Document Concerning Use of Pilot Manufacturing Facilities for the

Read the full 390 word article

How to gain access

Continue reading with a
two-week free trial.